Accretion Pharmaceuticals Limited

Accretion Pharmaceuticals Limited - pharma in Sanand, Gujarat, India. FY 2026 financials and compliance.
CIN L21004GJ2023PLC146545 Incorporated 29 November 2023 ROC Ahmedabad HQ Sanand, Gujarat, India
Active Listed Public Limited Company pharma
Data last updated
Revenue · FY 2025
₹57.47 Cr
▲ 329.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹13 Cr
Registered with MCA
Paid-up capital
₹11.12 Cr
Issued & subscribed
Open charges
₹13 Cr
Secured borrowings
Company age
3 yrs
Est. 2023
Last financials
Mar 2025
Balance sheet date

About Accretion Pharmaceuticals Limited

Data last updated: 14 July 2026

Accretion Pharmaceuticals Limited is a public limited company based in Sanand, Gujarat, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 29 November 2023.

Registered with ROC Ahmedabad under CIN U21004GJ2023PLC146545. Listed.

Capital: an authorised share capital of ₹13 Cr and a paid-up capital of ₹11.12 Cr. It is led by directors including Hardik Mukundbhai Prajapati and Harshad Nanubhai Rathod.

Last AGM: 25 September 2025. Financial statements filed for year ended 31 March 2025. Office: 29 Xcelon Ind Park, Sanand, Gujarat.

As per the financials filed for FY 2025, the company reported a revenue of ₹57.47 Cr, reflecting significant growth compared to the previous year.

As per MCA filings, the company has open charges of ₹13 Cr on record.

For more details, the company can be reached via its website accretion.co.in.

Company Details of Accretion Pharmaceuticals Limited
CIN L21004GJ2023PLC146545
Registration Number 146545
Incorporation Date 29 November 2023
ROC Ahmedabad
Listing Status Listed
Company Status Active
Date of Last AGM 25 September 2025
Date of Balance Sheet 31 March 2025
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
    Locked
  • Registered Address
    29 Xcelon Ind Park 1 B/H, Intas Pharmaceuticals, Sanand, Gujarat, India – 382213
  • Industry
    Pharma, Drug Formulation & Development
Company report
Accretion Pharmaceuticals Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Accretion Pharmaceuticals Limited report

Financials, compliance, directors, charges, ownership and filings for Accretion Pharmaceuticals Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Accretion Pharmaceuticals Limited

Accretion Pharmaceuticals Limited has one previous CIN (Corporate Identification Number): U21004GJ2023PLC146545. The current CIN is L21004GJ2023PLC146545, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L21004GJ2023PLC146545 Current
U21004GJ2023PLC146545 Previous

Business Activity of Accretion Pharmaceuticals Limited

Accretion Pharmaceuticals Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Accretion Pharmaceuticals Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Accretion Pharmaceuticals Limited

Accretion Pharmaceuticals Limited is audited by K M V & CO for the financial year 2024. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
K M V & CO Locked Locked Locked
Premium access

Complete auditor history for Accretion Pharmaceuticals Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Accretion Pharmaceuticals Limited

Accretion Pharmaceuticals Limited is currently managed by 7 directors, with 7 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Hardik Mukundbhai Prajapati Director 29 Nov 2023 2 Years 7 Months Current
Harshad Nanubhai Rathod Director 29 Nov 2023 2 Years 7 Months Current
Mayur Popatlal Sojitra Director 29 Nov 2023 2 Years 7 Months Current
Vivek Ashok Kumar Patel Managing Director 29 Nov 2023 2 Years 7 Months Current
Chand Rameshbhai Kanabar Director 19 Apr 2025 1 Years 3 Months Current
Grishma A Shewale Director 09 Jul 2024 2 Years 0 Months Current
Showing 6 of 7 current directors. View all directors

Financials of Accretion Pharmaceuticals Limited FY 2025 filings available

Accretion Pharmaceuticals Limited reported revenue of ₹57.47 Cr (up 329.00% YoY) for FY 2025.

Revenue · FY 2025
₹57.47 Cr ▲ 329.00%
Premium access

Ten-year financial statements for Accretion Pharmaceuticals Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Accretion Pharmaceuticals Limited

Premium access

Shareholding and ownership data for Accretion Pharmaceuticals Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Accretion Pharmaceuticals Limited

Open charges
₹13 Cr
Satisfied charges
₹0
Breakdown by lending institutions
Indian Bank₹13.00 Cr
Latest charge details
DateLenderAmountStatus
05 Jan 2024 Indian Bank ₹13 Cr Open

Total charge records: 1 View all charges

Employees and EPFO Compliance at Accretion Pharmaceuticals Limited

Accretion Pharmaceuticals Limited has a workforce of 0 employees as of Oct 23, 2024.

Active EPFO establishments
1
Premium access

Employee and EPFO history for Accretion Pharmaceuticals Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Accretion Pharmaceuticals Limited

Premium access

GST registrations and filing compliance for Accretion Pharmaceuticals Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Accretion Pharmaceuticals Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Accretion Pharmaceuticals Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Accretion Pharmaceuticals Limited

Premium access

MSME payment history for Accretion Pharmaceuticals Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Accretion Pharmaceuticals Limited

Premium access

Corporate group structure for Accretion Pharmaceuticals Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Accretion Pharmaceuticals Limited

Premium access

MCA filings and documents for Accretion Pharmaceuticals Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Accretion Pharmaceuticals Limited

Charges
19 Jan 2026
A charge with Indian Bank of Rs. 13.00 Cr registered on 05 Jan 2024 with Charge ID 100844260 was modified on 19 Jan 2026.
Directors
27 Sep 2025
Roshni Dharmendrabhai Shah was appointed as a Company Secretary on 27 Sep 2025 & has been associated with this company since 9 months 27 days.
Activity
25 Sep 2025
Accretion Pharmaceuticals Limited last Annual general meeting of members was held on 25 Sep 2025 as per latest MCA records.
Directors
10 Jun 2025
Nishtha Harivanshi Pamnani was appointed as a Director on 10 Jun 2025 & has been associated with this company since 1 year 1 month.
Directors
19 Apr 2025
Chand Rameshbhai Kanabar was appointed as a Director on 19 Apr 2025 & has been associated with this company since 1 year 3 months.
Activity
31 Mar 2025
Accretion Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.

Frequently Asked Questions about Accretion Pharmaceuticals Limited

Accretion Pharmaceuticals Limited is an active public limited company in the pharma sector based in Sanand, Gujarat, India. It was incorporated on 29 November 2023 (3+ years old) and is registered under CIN L21004GJ2023PLC146545.

Accretion Pharmaceuticals Limited reported revenue of ₹57.47 Cr for FY 2025 (up 329.00% YoY).

The current directors of Accretion Pharmaceuticals Limited are:

The primary industry of Accretion Pharmaceuticals Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Yes, Accretion Pharmaceuticals Limited is a listed company.

Accretion Pharmaceuticals Limited can be reached at the registered office: 29 Xcelon Ind Park 1 BH, Intas Pharmaceuticals, Sanand, Gujarat, India – 382213, or through the website accretion.co.in.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available